Chemotherapy of leprosy: theoretical basis of new guideline in Japan

5Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

For the effective treatment of leprosy, we should consider that (1) more time is needed for the elimination of bacilli than ordinary bacterial infection, (2) bactericidal therapy often induces host immunity called reactions, (3) rapid treatment is needed for the reactions. Last year, ad hoc committee of Japanese Leprosy Association recommends standard treatment protocol of leprosy in Japan, which is a modification of World Health Organization's multidrug therapy. For multibacillary(MB) with bacterial index (BI > or = 3) before treatment, 2 years treatment by rifampicin, dapsone and clofazimine (MDT/MB) is necessary. When BI decrease is not satisfactory(BI value decrease < 2 steps, or final BI > or = 3) after 2 years, MDT/MB should be continued until BI negativity and loss of active lesions. Theoretical background of our proposal is described.

Cite

CITATION STYLE

APA

Goto, M. (2001). Chemotherapy of leprosy: theoretical basis of new guideline in Japan. Nihon Hansenbyō Gakkai Zasshi = Japanese Journal of Leprosy : Official Organ of the Japanese Leprosy Association. https://doi.org/10.5025/hansen.70.151

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free